biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by lovetheoilpatchon May 10, 2015 4:58pm

126 Views

Post# 23713306

RE:RE:An Honest Answer here is Needed

When is the company going to finally step on the gas and start getting the word out on what we have ..what it does...and what it can do for you....the promotion has been a tradgedy...a crime even if you will....this should be on alot of peoples radars..... 2500 share average trading in the states per day is not good..... the time to strike is now!!!!!...this cant keep waiting....so they not realize this in their head office?...

Bullboard Posts

Southern Ontario mineral processing operation receives green fund support